Paul Pronyk1, Braeden Rogers1, Sylvia Lee1, Aarunima Bhatnagar1, Yaron Wolman1, Roeland Monasch1, David Hipgrave1, Peter Salama1, Adam Kucharski1, Mickey Chopra1. 1. Paul Pronyk, Braeden Rogers, Mickey Chopra, David Hipgrave, and Peter Salama are with UNICEF Headquarters, New York, NY. Paul Pronyk is also with the School of Public Health, University of the Witwatersrand, Johannesburg, South Africa. Sylvia Lee, Aarunima Bhatnagar, Yaron Wolman, and Roeland Monasch are with UNICEF Sierra Leone, Freetown. Adam Kucharski is with Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, England.
Abstract
OBJECTIVES: To examine the acceptability, use, effects on early isolation, and contribution to Ebola virus disease (EVD) transmission of Community Care Centers (CCCs), which were rapidly deployed in Sierra Leone during an accelerated phase of the 2014-2015 EVD epidemic. METHODS: Focus group discussions, triads, and key informant interviews assessed acceptability of the CCCs. Facility registers, structured questionnaires, and laboratory records documented use, admission, and case identification. We estimated transmission effects by comparing time between symptom onset and isolation at CCCs relative to other facilities with the national Viral Hemorrhagic Fever data set. RESULTS: Between November 2014 and January 2015, 46 CCCs were operational. Over 13 epidemic weeks, 6129 patients were triaged identifying 719 (12%) EVD suspects. Community acceptance was high despite initial mistrust. Nearly all patients presented to CCCs outside the national alert system. Isolation of EVD suspects within 4 days of symptoms was higher in CCCs compared with other facilities (85% vs 49%; odds ratio = 6.0; 95% confidence interval = 4.0, 9.1), contributing to a 13% to 32% reduction in the EVD reproduction number (Ro). CONCLUSIONS: Community-based approaches to prevention and care can reduce Ebola transmission.
OBJECTIVES: To examine the acceptability, use, effects on early isolation, and contribution to Ebola virus disease (EVD) transmission of Community Care Centers (CCCs), which were rapidly deployed in Sierra Leone during an accelerated phase of the 2014-2015 EVD epidemic. METHODS: Focus group discussions, triads, and key informant interviews assessed acceptability of the CCCs. Facility registers, structured questionnaires, and laboratory records documented use, admission, and case identification. We estimated transmission effects by comparing time between symptom onset and isolation at CCCs relative to other facilities with the national Viral Hemorrhagic Fever data set. RESULTS: Between November 2014 and January 2015, 46 CCCs were operational. Over 13 epidemic weeks, 6129 patients were triaged identifying 719 (12%) EVD suspects. Community acceptance was high despite initial mistrust. Nearly all patients presented to CCCs outside the national alert system. Isolation of EVD suspects within 4 days of symptoms was higher in CCCs compared with other facilities (85% vs 49%; odds ratio = 6.0; 95% confidence interval = 4.0, 9.1), contributing to a 13% to 32% reduction in the EVD reproduction number (Ro). CONCLUSIONS: Community-based approaches to prevention and care can reduce Ebola transmission.
Authors: P Farmer; F Léandre; J S Mukherjee; M Claude; P Nevil; M C Smith-Fawzi; S P Koenig; A Castro; M C Becerra; J Sachs; A Attaran; J Y Kim Journal: Lancet Date: 2001-08-04 Impact factor: 79.321
Authors: Paul M Pronyk; James R Hargreaves; Julia C Kim; Linda A Morison; Godfrey Phetla; Charlotte Watts; Joanna Busza; John D H Porter Journal: Lancet Date: 2006-12-02 Impact factor: 79.321
Authors: Adam J Kucharski; Anton Camacho; Francesco Checchi; Ron Waldman; Rebecca F Grais; Jean-Clement Cabrol; Sylvie Briand; Marc Baguelin; Stefan Flasche; Sebastian Funk; W John Edmunds Journal: Emerg Infect Dis Date: 2015-03 Impact factor: 6.883
Authors: Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti Journal: N Engl J Med Date: 2014-09-22 Impact factor: 91.245
Authors: Shefali Oza; Darius Jazayeri; Jonathan M Teich; Ellen Ball; Patricia Alexandra Nankubuge; Job Rwebembera; Kevin Wing; Alieu Amara Sesay; Andrew S Kanter; Glauber D Ramos; David Walton; Rachael Cummings; Francesco Checchi; Hamish S Fraser Journal: J Med Internet Res Date: 2017-08-21 Impact factor: 5.428
Authors: Mohamed F Jalloh; Paul Sengeh; Nyuma James; Saiku Bah; Mohammad B Jalloh; Katharine Owen; Samuel Abu Pratt; Allan Oniba; Musa Sangarie; Samuel Sesay; Jamie Bedson Journal: BMJ Glob Health Date: 2020-12
Authors: Ibrahim Yusuf; Auwalu Halliru Arzai; Muhammad Yusha U; Lawal Garba; Musa Haruna; Muhammad Ibrahim Getso Journal: Pan Afr Med J Date: 2021-10-22
Authors: Stephen R Kodish; Frank Bio; Rachel Oemcke; James Conteh; Jean Max Beauliere; Solade Pyne-Bailey; Fabian Rohner; Ismael Ngnie-Teta; Mohammad B Jalloh; James P Wirth Journal: PLoS Negl Trop Dis Date: 2019-09-10